Gallium-68 Citrate PET Used in Prostate Cancer
Early Phase 1
Completed
- Conditions
- Prostatic Neoplasms
- Interventions
- Drug: Gallium-68 citrateProcedure: Positron Emission Tomography (PET)
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Rahul Aggarwal
- Target Recruit Count
- 39
- Registration Number
- NCT02391025
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer
Phase 1
Completed
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2012-05-09
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Rahul Aggarwal
- Target Recruit Count
- 25
- Registration Number
- NCT01594918
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸Mayo Clinic, Scottsdale, Arizona, United States
🇺🇸UCSF Comprehensive Cancer Center, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath